New adenovirus vectors for protein production and gene transfer

被引:53
|
作者
Massie, B
Mosser, DD
Koutroumanis, M
Vitté-Mony, I
Lamoureux, L
Couture, F
Paquet, L
Guilbault, C
Dionne, J
Chahla, D
Jolicoeur, P
Langelier, Y
机构
[1] Inst Rech Biotechnol, Montreal, PQ H4P 2R2, Canada
[2] Univ Montreal, Inst Canc Montreal, Ctr Rech Louis Charles Simard, Montreal, PQ H2L 4M1, Canada
关键词
adenoviral recombinant; functional genomics; gene therapy; green fluorescent protein; inducible gene expression; protein production;
D O I
10.1023/A:1008013211222
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Based on two new adenovirus expression cassettes, we have constructed a series of Ad transfer vectors for the overexpression of one or two genes either in a dicistronic configuration or with separate expression cassettes. Inclusion of the green or blue fluorescent protein in the vectors accelerates the generation of adenovirus recombinants and facilitates the functional characterization of genes both in vitro and in vivo by allowing easy quantification of gene transfer and expression. With our optimized tetracycline-regulated promoter (TR5) we have generated recombinant adenoviruses expressing proteins, that are either cytotoxic or which interfere with adenovirus replication, at levels of 10-15% of total cell protein. Proteins that are not cytotoxic can be produced at levels greater than 20% of total cell protein. As well, these levels of protein production can be achieved with or without adenovirus replication. This yield is similar to what can be obtained with our optimized human cytomegalovirus-immediate early promoter-enhancer (CMV5) for constitutive protein expression in non-complementing cell lines. Using the green fluorescent protein as a reporter, we have shown that a pAdCMV5-derived adenovirus vector expresses about 6-fold more protein in complementing 293 cells and about 12-fold more in non-complementing HeLa cells than an adenovirus vector containing the standard cytomegalovirus promoter. Moreover, a red-shifted variant of green fluorescent protein incorporated in one series of vectors was 12-fold more fluorescent than the S65T mutant, making the detection of the reporter protein possible at much lower levels of expression.
引用
收藏
页码:53 / 64
页数:12
相关论文
共 50 条
  • [1] New adenovirus vectors for protein production and gene transfer
    Bernard Massie
    Dick D. Mosser
    Maria Koutroumanis
    Isabelle Vitté-mony
    Linda Lamoureux
    France Couture
    Luc Paquet
    Claire Guilbault
    Julie Dionne
    Dounia Chahla
    Pierre Jolicoeur
    Yves Langelier
    Cytotechnology, 1998, 28 : 53 - 64
  • [2] Improvement of adenovirus vectors for gene transfer
    Mizuguchi, H
    Hayakawa, T
    ANIMAL CELL TECHNOLOGY : BASIC & APPLIED ASPECTS, VOL 12, 2002, : 1 - 5
  • [3] Canine adenovirus vectors: an alternative for adenovirus mediated gene transfer
    Kremer, EJ
    Boutin, S
    Chillon, M
    Danos, O
    JOURNAL OF VIROLOGY, 2000, 74 (01) : 505 - 512
  • [4] TRANSFER OF A FOREIGN GENE INTO THE BRAIN USING ADENOVIRUS VECTORS
    AKLI, S
    CAILLAUD, C
    VIGNE, E
    STRATFORDPERRICAUDET, LD
    POENARU, L
    PERRICAUDET, M
    KAHN, A
    PESCHANSKI, MR
    NATURE GENETICS, 1993, 3 (03) : 224 - 228
  • [5] Utilization of adenovirus vectors for multiple gene transfer applications
    Amalfitano, A
    METHODS, 2004, 33 (02) : 173 - 178
  • [7] Adenovirus vectors for gene transfer into colorectal cancer cells for gene therapy
    Lal, S
    Ali, S
    Dewey, R
    Millan, E
    Lowenstein, P
    Castro, M
    Watson, AJM
    GUT, 1998, 42 : A1 - A1
  • [8] Production of adenovirus vectors
    Kamen, A
    Nadeau, I
    BIOFUTUR, 2004, (242) : 37 - 41
  • [9] Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm
    Aldhamen, Yasser Ali
    Seregin, Sergey S.
    Amalfitano, Andrea
    FRONTIERS IN IMMUNOLOGY, 2011, 2
  • [10] Recombinant adenovirus vectors with knobless fibers for targeted gene transfer
    van Beusechem, VW
    van Rijswijk, ALCT
    van Es, HHG
    Haisma, HJ
    Pinedo, HM
    Gerritsen, WR
    GENE THERAPY, 2000, 7 (22) : 1940 - 1946